Compounds > tosyllysine chloromethyl ketone

tosyllysine chloromethyl ketone and Carcinoma, Anaplastic

tosyllysine chloromethyl ketone has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bem, D; Davies, CC; Eliopoulos, AG; Young, LS	1

Other Studies

1 other study(ies) available for tosyllysine chloromethyl ketone and Carcinoma, Anaplastic

Article	Year
NF-kappaB overrides the apoptotic program of TNF receptor 1 but not CD40 in carcinoma cells. Cellular signalling, 2005, Volume: 17, Issue:6 Topics: Apoptosis; Carcinoma; CD40 Antigens; CD40 Ligand; Enzyme Inhibitors; HeLa Cells; Humans; I-kappa B Proteins; Mutation; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Tosyllysine Chloromethyl Ketone; Tumor Necrosis Factor-alpha	2005

Article

Year

NF-kappaB overrides the apoptotic program of TNF receptor 1 but not CD40 in carcinoma cells.

Cellular signalling, 2005, Volume: 17, Issue:6

Topics: Apoptosis; Carcinoma; CD40 Antigens; CD40 Ligand; Enzyme Inhibitors; HeLa Cells; Humans; I-kappa B Proteins; Mutation; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Tosyllysine Chloromethyl Ketone; Tumor Necrosis Factor-alpha

2005